Explore evidence

Plasmodium ovale was sensitive to all tested drugs within the follow-up periods and on interpretable in vitro assays.

Gabonpaludismepublished 2017Malaria journalPubMeddocument of 4 observations

12.9 %70 malaria interventional trials (12.9%) were registered following study completion.

Gabonpaludismeobserved 2010 to 2020published 2024Malaria journalPubMeddocument of 13 observations

12 %During a period of one year, 12% of the thick blood smears from the 497 afebrile males screened showed Plasmodium falciparum with low parasitemias in villages near Lambaréné, Gabon.

Gabonpaludismeobserved one yearpublished 2007The American journal of tropical medicine and hygieneeurope_pmcdocument of 4 observationsDOI 10.4269/ajtmh.2007.77.939

217 patientsThe study included 217 patients (111 malaria patients and 106 symptomatic controls, defined as malaria-negative febrile patients).

Gabonpaludismepublished 2017The American journal of tropical medicine and hygieneeurope_pmcdocument of 3 observations

5.3 %Sub-microscopic Plasmodium ovale infection had a prevalence of 5.3% among participants.

Gabonpaludismeobserved 2021published 2022Parasites & vectorseurope_pmcdocument of 7 observations

1.1 %The prevalence of the rdl A269G mutation in Anopheles mosquitoes from the Bijagós Archipelago was 1.1%.

Gabonpaludismeobserved 2019published 2024Parasites & vectorsPubMeddocument of 6 observations

Females aged ≥ 11 years made significantly higher levels of antibodies to PfCSP than males in most trials.

Gabonpaludismepublished 2022Frontiers in immunologyPubMeddocument of 5 observations

0 per_19No secondary treatment failures occurred in recrudescence cases retreated with AL (0/19).

Gabonpaludismepublished 2025Tropical diseases, travel medicine and vaccinesPubMeddocument of 5 observations

0.02 correlation_coefficientThe correlation between antibodies to the C-terminal region of CSP and RTS,S/AS01 response was r = 0·02 [-0·10 to 0·15].

Gabonpaludismepublished 2025The Lancet. Infectious diseasesPubMeddocument of 11 observations

4.9 odds_ratioDiarrhoea was a risk factor for recrudescence in the cohort, with an unadjusted odds ratio of 4.9 (95% CI: 1.14–21.06).

Gabonpaludismepublished 2025Tropical diseases, travel medicine and vaccinesPubMeddocument of 5 observations

3.1 nMThe mean concentration required to inhibit 50% of growth (IC50) of Plasmodium malariae with atovaquone was 3.1 nM.

Gabonpaludismepublished 2025Pathogens (Basel, Switzerland)europe_pmcdocument of 4 observations

58 %In 2005–07, 58% of the isolates carried the same microsatellite alleles in a chromosomal fragment spanning 39 kb surrounding the pfcrt locus.

Gabonpaludismeobserved 2005 - 07published 2011Malaria journaleurope_pmcdocument of 4 observationsDOI 10.1186/1475-2875-10-304

95 %In part B, the PCR-corrected adequate clinical and parasitological response at day 29 was 95% (95% CI 83–99) for the 3-day regimen of ganaplacide 400 mg plus lumefantrine-SDF 960 mg in children.

Gabonpaludismepublished 2023The Lancet. Infectious diseasesPubMeddocument of 10 observations

Prevalence of chloroquine-resistant Plasmodium falciparum remains high, especially in rural areas.

Gabonpaludismepublished 2019Malaria journaleurope_pmcdocument of 4 observationsDOI 10.1186/s12936-019-2972-y

39 samplesIC50 was successfully determined in 39 out of 46 samples from malaria patients in Gabon.

Gabonpaludismepublished 2015Malaria journalPubMeddocument of 4 observations

200,000,000 casesMalaria results in more than 200 million clinical cases annually.

Gabonpaludismepublished 2015VaccinePubMeddocument of 2 observations

7 genotypes_per_sampleThe highest combined genotype complexity in samples that contained mixed-species infections was seven.

Gabonpaludismepublished 2017Malaria journaleurope_pmcdocument of 6 observations

Malaria is one of the leading causes of morbidity and mortality in African countries.

Gabonpaludismepublished 2021Malaria journalPubMeddocument of 9 observations

Women with moderate or severe anaemia had higher parasite prevalences and densities.

Gabonanémie · paludismepublished 2003Malaria JournalOpenAlexdocument of 5 observationsDOI 10.1186/1475-2875-2-18

26.1 %The global clinical cases of malaria were 26.1% (658/2015) in Franceville between 2017 and 2019.

Gabonpaludismeobserved 2017-2019published 2023Journal of public health in Africaeurope_pmcdocument of 7 observationsDOI 10.4081/jphia.2023.1865

7.69 %Among 70 malaria-positive patient samples screened for polymorphism in Libreville, Gabon, the alternative alanine/phenylalanine mutation at SA/F in Pfdhps occurred in 7.69% (n = 5) of samples.

Gabonpaludismepublished 2023Malaria journalPubMeddocument of 11 observations

460,000 cases_per_yearGabon is a high-transmission malaria country with more than 460,000 malaria cases per year.

Gabonpaludismepublished 2021Antimicrobial agents and chemotherapyeurope_pmcdocument of 4 observations

5 participantsTwelve weeks following immunization, 5 out of 5 participants receiving placebo developed parasitemia after controlled human malaria infection (CHMI) using the Pf7G8 strain.

Gabonpaludismepublished 2021Nature communicationsPubMeddocument of 4 observations

31.5 %Malaria prevalence in Franceville was 31.5% in 2021.

Gabonpaludismeobserved 2021published 2022BMC Public HealthOpenAlexdocument of 8 observationsDOI 10.1186/s12889-022-14765-7

13.3 %Plasmodium spp. was detected in 13.3% of afebrile children (8 out of 60) in Gabon.

Gabonpaludismepublished 2016The American journal of tropical medicine and hygieneeurope_pmcdocument of 9 observations